Analystreport

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "hold" rating. They now have a $14.00 price target on th

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com